Retatrutide 20mg Injection (Lyophilized)

Retatrutide 20mg Injection is a research-grade, lyophilized peptide formulation supplied in sterile pharmaceutical vials for advanced pharmaceutical research and development applications. Retatrutide is a laboratory-synthesized peptide evaluated in controlled metabolic and multi-receptor research programs.

This Retatrutide 20mg Injection is manufactured and supplied strictly for international export to licensed research institutions, biotechnology companies, and pharmaceutical R&D organizations. It is not intended for clinical treatment, retail distribution, or consumer use.

Active Ingredient

Retatrutide 20mg Injection
Retatrutide is a synthetic peptide compound studied exclusively in controlled laboratory environments for its interaction with multiple metabolic receptor pathways.

Intended Research Use

Retatrutide 20mg Injection is supplied for pharmaceutical research and R&D use only. It is intended exclusively for:

• Non-clinical laboratory research
• Analytical and characterization studies
• Formulation and stability development
• Investigational research programs conducted by authorized institutions

AmeriDrugs does not provide medical advice, therapeutic claims, dosing guidance, or recommendations for human use.

Dosage Form & Presentation

• Sterile lyophilized powder for injection
• Supplied in sealed pharmaceutical-grade glass vials
• Reconstitution, handling, and experimental use of Retatrutide 20mg Injection must be performed only by qualified research professionals under approved institutional protocols

Quality & Manufacturing Standards

Each batch of Retatrutide 20mg Injection is manufactured in a controlled environment following stringent quality management systems aligned with international research material and export standards.

• Purity: ≥99% by HPLC
• Research-grade injectable material
• Validated analytical testing for identity, purity, and consistency
• Documented quality assurance and batch traceability

Packaging Information

• Sterile amber glass vial
• Aluminum flip-off seal with rubber stopper
• Secure secondary packaging suitable for international shipping
• Packaging designed to preserve the integrity of Retatrutide 20mg Injection during storage and long-term research use

Target Buyers

Retatrutide 20mg Injection is supplied exclusively to:

• Pharmaceutical research and development companies
• Biotechnology and life science research firms
• Academic and institutional research laboratories
• Contract Research Organizations (CROs)
• Licensed importers of research-grade injectable materials

This product is not intended for retail sale, prescription dispensing, clinical treatment, or direct human consumption.

Regulatory & Compliance Notice

Retatrutide 20mg Injection is supplied strictly as a Research Use Only (RUO) product.

• For pharmaceutical research and R&D use only
• Not for retail sale, clinical use, diagnostic use, or human consumption

Importation, storage, handling, and use of Retatrutide 20mg Injection must comply with all applicable regulatory, customs, and research material requirements of the destination country. AmeriDrugs operates solely as an export-focused pharmaceutical and research material supplier and does not promote this product for therapeutic or patient-facing applications.